Compare American States Water Company (AWR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American States Water Company vs BIO-TECHNE Corp — how do they compare? American States Water Company trades at $87.74 (market cap $3.43B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 3.3× American States Water Company's market cap, and American States Water Company pays the higher dividend (2.52%). Which is the better fit depends on your goals.
| AWR | TECH | |
|---|---|---|
Market Cap | $3.43B | $11.24B |
Sector | Utilities | Health |
52-Week High | $89.28 | $72.29 |
52-Week Low | $70.10 | $43.31 |
Enterprise Value | $4.33B | $11.32B |
Dividend Yield | 2.52% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
American States Water (AWR) trades at $87.39, up 2.01% today, with strong technical momentum showing bullish moving averages and support at $86. The company reported Q2 2026 EPS of $1.09, beating estimates by 19.1%, driven by water rate increases and 11.2% revenue growth. AWR maintains exceptional profitability with 20.52% net margins and recently announced an 8.2% dividend increase, extending its 71-year dividend growth streak.
While AWR demonstrates operational excellence and dividend reliability, the stock faces valuation concerns with a P/E of 23.65 above sector averages. Analyst sentiment is mixed with only 20% buy ratings, reflecting concerns about limited upside. Regulatory dependency and high capital expenditures present ongoing risks, though the company's monopoly position and infrastructure investments provide stability.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American States Water Company
American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.
Read more on AWR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
